$68.61 +0.44 (0.65%) Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh - New York Stock Exchange, Inc.

Dec. 5, 2016 | 09:39 AM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 68.61
Trade Time: Dec 05 09:39 AM Eastern Daylight Time
Change: +0.44 (0.65%)
Prev Close: 68.17
Open: 68.66
Bid: 68.59
Ask: 68.62
  1. Lung Disease Stocks Advance After Actelion Approached By J&J

    TalkMarkets | Nov. 25, 2016 | 17:04PM EST
  2. Calithera In Focus, Part 2 - Upcoming Catalysts In TNBC And RCC

    TalkMarkets | Nov. 23, 2016 | 11:45AM EST
  3. Batten Down The Bonds

    TalkMarkets | Nov. 14, 2016 | 23:38PM EST
  4. Markets In Turmoil: Global Bond Bloodbath, Currency Rout Accelerates As Stocks Erase Early Gains

    TalkMarkets | Nov. 14, 2016 | 06:53AM EST
  5. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  6. IPO Preview: Ra Pharmaceuticals

    TalkMarkets | Oct. 26, 2016 | 01:02AM EST
  7. Apple Bites - Financial Review

    TalkMarkets | Oct. 25, 2016 | 23:03PM EST
  8. Novartis Tops Q3 Earnings, Misses Sales Estimates

    TalkMarkets | Oct. 25, 2016 | 12:47PM EST
  9. Phase 2b Data Continues To Impress From HedgePath Pharma

    TalkMarkets | Oct. 21, 2016 | 04:18AM EST
  10. 7 Drug Stocks To Consider As Biosimilars Pick Up Pace

    TalkMarkets | Oct. 20, 2016 | 13:53PM EST
  11. Bristol-Myers Falls As Merck Upstages With New Lung Cancer Data

    TalkMarkets | Oct. 10, 2016 | 18:35PM EST
  12. Week In Review: Teva Pays $160 Million For US/Canada Rights To Celltrion Biosimilars

    TalkMarkets | Oct. 8, 2016 | 13:30PM EST
  13. 10 Stocks John Rogers Keeps Buying

    GuruFocus | Sep. 27, 2016 | 16:59PM EST
  14. Kite Pharma Soars As Cancer Drug Trial Supportive Of FDA Approval

    IBD | Sep. 27, 2016 | 15:20PM EST
  15. Kite Pharma Jumps After CAR-T Cancer Drug Success

    TalkMarkets | Sep. 26, 2016 | 22:04PM EST
Trading Center